Summary
- Current Price
- As of today, QGEN price is $41.78, down -5.20% on
- Current Price All-Time High
- QGEN price is currently -33.43% below its historical high of $62.76 set on
- Market Cap
- QGEN current market cap is $9B, down -15.80% year-over-year
- PE Ratio
- QGEN current PE ratio is 21.22
- Revenue
- QGEN current annual revenue is $2.09B, up +5.65% year-over-year
- Next Earnings
- The next earnings release for QGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Qiagen N.V. |
| Ticker | NYSE: QGEN |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | Netherlands |
| IPO | |
| Indexes | Not included |
| Website | qiagen.com |
| Employees | 5,700 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $41.78 | |
| Price, 1D Change | -5.20% | |
| Market Cap | $9B | |
| TTM Dividend Yield | 6.32% | |
| PE Ratio | 21.22 | |
| Beta | 0.34 | |
| Revenue | $2.09B | |
| Revenue, 1Y Change | +5.65% | |
| EPS | $2.04 | |
| EPS, 1Y Change | +407.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.35 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 19:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $2.04 | |
| EPS Estimate | $2.43 | N/A |
| EPS Est. Change | +19.11% | N/A |
| Revenue | $2.09B | |
| Revenue Estimate | $2.14B | N/A |
| Revenue Est. Change | +2.54% | N/A |
| Current Price | $41.78 | |
| Price Target | $46.50 | - |
| Price Tgt. Change | +11.30% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.24 | $0.40 | -82.00% | |
| $2.48 | $2.04 | -17.64% | |
| $2.43 | N/A | +19.11% | |
| $2.61 | N/A | +27.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.98B | $1.98B | -0.06% | |
| $2.08B | $2.09B | +0.62% | |
| $2.14B | N/A | +2.54% | |
| $2.25B | N/A | +7.74% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -16.00% | |
| Price, 3Y | -8.67% | |
| Market Cap, 1Y | -15.80% | |
| Market Cap, 3Y | -12.36% | |
| Revenue, 1Y | +5.65% | |
| Revenue, 3Y | -2.41% | |
| EPS, 1Y | +407.40% | |
| EPS, 3Y | +7.78% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $41.78 | |
| SMA 200 | $42.75 | |
| SMA 50 | $40.77 | |
| EMA 200 | $41.90 | |
| EMA 50 | $41.20 | |
| $0.76 | ||
| Beta | 0.34 | |
| ATR | $1.27 | |
| 14-Day RSI | 47.97 | |
| 10-Day Volatility | 42.47% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.35 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.61% | |
| Total Dividend | $1.51 | |
| $54.24M | ||
| 12.77% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $2.09B | |
| EPS | $2.04 | |
| Gross Profit | $1.29B | |
| Gross Margin | 61.79% | |
| Operating Income | $520.31M | |
| Operating Margin | 24.90% | |
| Net Income | $424.88M | |
| Net Margin | 20.33% | |
| EBITDA | $714.06M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.44 | |
| 3.90 | ||
| 3.31 | ||
| - | ||
| 6 | ||
| 3.57 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 21.22 | |
| 4.11 | ||
| 2.57 | ||
| 13.18 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $3.78B | |
| $1.10B | ||
| $6.28B | ||
| $2.00B | ||
| $2.50B | ||
| $512.14M | ||
| Total Debt | $1.65B | |
| $0.00 | ||
| $72.66M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.67B | ||
| $771.19M | ||
| $798.50M | ||
| $0.00 | ||
| $193.75M | ||
| $0.00 | ||
| $65.39M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $654.33M | ||
| -$305.28M | ||
| -$178.98M | ||
| Capex | $207.13M | |
| $447.20M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Citigroup | → | |
| JP Morgan | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| Stifel | → | |
| TD Cowen | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Barclays | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with QGEN
FAQ
- What is the ticker symbol for Qiagen N.V.?
- The ticker symbol for Qiagen N.V. is NYSE:QGEN
- Does Qiagen N.V. pay dividends?
- Yes, Qiagen N.V. pays dividends. The last payment was $0.35, with an ex-dividend date on July 7, 2026
- What sector is Qiagen N.V. in?
- Qiagen N.V. is in the Healthcare sector
- What industry is Qiagen N.V. in?
- Qiagen N.V. is in the Diagnostics & Research industry
- What country is Qiagen N.V. based in?
- Qiagen N.V. is headquartered in Netherlands
- When did Qiagen N.V. go public?
- Qiagen N.V. initial public offering (IPO) was on June 28, 1996
- Is Qiagen N.V. in the S&P 500?
- No, Qiagen N.V. is not included in the S&P 500 index
- Is Qiagen N.V. in the NASDAQ 100?
- No, Qiagen N.V. is not included in the NASDAQ 100 index
- Is Qiagen N.V. in the Dow Jones?
- No, Qiagen N.V. is not included in the Dow Jones index
- When was Qiagen N.V. last earnings report?
- Qiagen N.V.'s most recent earnings report was on August 5, 2026
- When does Qiagen N.V. report earnings?
- The next expected earnings date for Qiagen N.V. is November 4, 2026
Data Sources & References
- QGEN Official Website www.qiagen.com
- QGEN Profile on Yahoo Finance finance.yahoo.com/quote/QGEN
- QGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qgen
